약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 2.

Table. 2.

Nationwide trends of cost, utilization, and proportion by PPI

Proportion of cost (million KRW) Proportion of utilization (thousand DDD)

2016 2017 2018 2019 2020 GR in 2020 2016 2017 2018 2019 2020 GR in 2020
Total 267,848 307,241 337,550 372,372 443,213 19.0% 288,013 330,922 364,584 400,649 473,821 18.3%

Pantoprazole 13.1% 11.8% 11.0% 10.7% 9.0% 0.1% 13.7% 12.1% 11.2% 10.7% 9.9% 4.2%
Rabeprazole 41.8% 39.3% 39.0% 38.5% 38.6% 19.1% 37.3% 35.0% 34.8% 34.5% 34.6% 11.2%
Omeprazole 5.4% 4.7% 4.2% 3.9% 3.5% 8.4% 6.5% 5.7% 5.1% 4.7% 4.3% 2.0%
Esomeprazole 35.6% 38.7% 40.6% 41.8% 44.0% 25.3% 38.4% 41.7% 43.8% 45.1% 46.5% 18.7%
Lansoprazole 4.1% 5.5% 5.2% 5.0% 4.9% 14.9% 4.0% 5.5% 5.1% 4.9% 4.7% 18.0%

GR in 2020 means the Growth Rate in 2020 compared with 2019.

DDD: Defined Daily Dose

Yakhak Hoeji 2021;65:276-83 https://doi.org/10.17480/psk.2021.65.4.276
© 2021 Yakhak Hoeji